FDA expands labeling for SmartLight

Article

Israeli computerized light box developer SmartLight this month got the go-ahead from the Food and Drug Administration for expanded labeling for its products. On June 14, the FDA cleared SmartLight’s claim that, compared with conventional

Israeli computerized light box developer SmartLight this month got the go-ahead from the Food and Drug Administration for expanded labeling for its products. On June 14, the FDA cleared SmartLight’s claim that, compared with conventional light boxes, the company’s motorized system substantially improves clinicians’ ability to see more detail in films. SmartLight submitted a study of more than 1000 radiologists reading quality control mammography films to back up its 510(k) filing (SCAN 5/26/99).

The FDA also cleared SmartLight’s claim that its viewing systems can reduce effects of age on the ability of older radiologists to see small, low-contrast objects. According to SmartLight, radiologists aged 45 to 60 viewing x-rays on its light boxes can detect smaller, lower-contrast objects than their 30-year-old colleagues can using conventional light boxes.

© 1999 Miller Freeman, Inc.All rights reserved.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.